Anticonvulsant Effect of Drugs by MES and PTZ Methods

Aim: Anticonvulsant effect of drugs by MES and PTZ method

References

1. Goodman, L. S., & Gilman, A. (2018). Goodman and Gilman’s The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.
2. Löscher, W., & Schmidt, D. (1988). Which animal models should be used in the search for new antiepileptic drugs? Epilepsy Research, 2(3), 145–181.
3. Turner, R. A. (1965). Screening Methods in Pharmacology. Academic Press.
4. Kulkarni, S. K. (1999). Handbook of Experimental Pharmacology. Vallabh Prakashan.

Objective

To evaluate the effectiveness of anticonvulsant drugs by observing their ability to suppress seizures in two distinct animal models: MES and PTZ-induced seizures.

Materials and Methods

Materials

• Laboratory rodents (mice or rats)
• Test drugs (e.g., Phenytoin, Sodium Valproate)
• Electroconvulsiometer (for MES model)
• Pentylenetetrazol (PTZ) solution (80 mg/kg)
• Anesthetic agents (if required)
• Control solution (e.g., saline)
• Stopwatch
• Data recording sheets
• Personal protective equipment (PPE)

A. MES (Maximal Electroshock Seizure) Method

Procedure:

1. Animal Preparation: Acclimate animals for 1 hour in the lab. Handle gently to minimize stress.
2. Baseline Activity: Record baseline behavioral parameters.
3. Drug Administration: Administer test drug (i.p. or oral) as per study design. Control group receives equivalent volume of saline.
4. Seizure Induction: After 30–60 minutes of drug administration, induce seizures using an electroconvulsiometer (e.g., 50 mA for 0.2 sec via corneal electrodes).
5. Observation: Record the duration of each seizure phase:
   1. Tonic flexion
   1. Tonic extension
   1. Clonic convulsions
   1. Stupor
   1. Recovery
6. Post-Experiment Monitoring: Observe animals until full recovery and provide appropriate care.

Sample Results Table:

Group	Tonic Flexion (s)	Tonic Extension (s)	Clonic Convulsions (s)	Stupor (s)	Recovery Time (s)
Control	5	12	8	20	40
Drug-treated	4	6	5	15	35

B. PTZ (Pentylenetetrazol-Induced Seizure) Method

Procedure:

1. Animal Preparation: Acclimate animals for 1 hour. Handle with care.
2. Baseline Activity: Record initial behavioral status.
3. Drug Administration: Administer the test drug intraperitoneally or orally. Control group receives saline.
4. Seizure Induction: 30–60 minutes post-drug, inject PTZ (80 mg/kg, i.p.) to induce seizures.
5. Observation: Monitor and record:
   1. Latency to myoclonic jerks
   1. Latency to clonic convulsions
   1. Latency to tonic convulsions
   1. Total recovery time
6. Post-Experiment Care: Monitor until complete recovery and treat animals ethically.

Sample Results Table:

Group	Latency to Myoclonic Jerks (s)	Latency to Clonic Convulsions (s)	Latency to Tonic Convulsions (s)	Recovery Time (s)
Control	45	60	75	100
Drug-treated	80	120	No tonic convulsions	150

Discussion

1. Seizure Phase Interpretation:

MES Model: Best for evaluating drugs effective against generalized tonic-clonic seizures. Reduction in tonic extension duration is a key indicator.

PTZ Model: Suitable for assessing drugs active against absence and myoclonic seizures. Increased latency to seizure onset indicates effectiveness.

2. Drug Efficacy Assessment: An effective anticonvulsant increases latency, reduces seizure severity, and may prevent specific seizure phases (e.g., tonic convulsions in PTZ).

3. Comparative Analysis: Compare seizure parameters between control and drug-treated groups to determine statistical and therapeutic significance.

Precautions

• Follow all ethical guidelines for animal handling and experimentation.
• Calibrate the electroconvulsiometer before each use to ensure accurate stimulation.
• Maintain consistent environmental conditions and gentle handling to reduce variability.